Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 30772098.
- Also identified by DOI 10.1016/j.jaad.2018.11.057.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Psoriasis is a chronic, inflammatory multisystem disease that affects up to 3.2% of the US population. This guideline addresses important clinical questions that arise in psoriasis management and care, providing recommendations based on the available evidence. The treatment of psoriasis with biologic agents will be reviewed, emphasizing treatment recommendations and the role of the dermatologist in monitoring and educating patients regarding benefits as well as associated risks.
Medical subject headings
- Biological Products
- Dermatologic Agents
- Psoriasis